MELLE, FEDERICA
MELLE, FEDERICA
Universita' degli Studi di MILANO
Mostra
records
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.0 secondi).
Immune Signatures Identify Patient Subsets Deriving Long-Term Benefit From First-Line Rituximab in Follicular Lymphoma
2025 G. Lolli, A. Davini, V. Tabanelli, M. Sapienza, F. Melle, G. Motta, M. Del Corvo, A. Calleri, A. Vanazzi, P. Nierychlewska, A. Maraglino, M. Castelli, M. Quattrocchi, R. Chiarle, S. Pileri, C. Tarella, E. Derenzini
Venetoclax Plus Intensified Chemoimmunotherapy as a Bridge to Allogeneic Stem Cell Transplantation in Richter Syndrome: Report of Two Cases
2024 E. Derenzini, A. Cignetti, V. Tabanelli, D. Gottardi, E. Gerbino, A. Vanazzi, S. Sammassimo, A. Maraglino, F. Melle, G. Motta, D. Malengo, E. Omodeo Salè, L. Bonello, R. Pastano, S. Pileri, F. Carnevale Schianca, C. Tarella
Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
---|---|---|---|---|---|
Immune Signatures Identify Patient Subsets Deriving Long-Term Benefit From First-Line Rituximab in Follicular Lymphoma | 2025 | Davini AMelle FVanazzi ACastelli MTarella CDerenzini E + | Article (author) | - | |
Venetoclax Plus Intensified Chemoimmunotherapy as a Bridge to Allogeneic Stem Cell Transplantation in Richter Syndrome: Report of Two Cases | 2024 | Derenzini EVanazzi AMelle FBonello LTarella C + | Article (author) | - |